Advertisement

Proinflammatory cytokine and cancer

 

American Journal of BioMedicine  Volume 2, Issue 12, pages1210-1221 December 2014


Song Zheng; Wu Wang; Devi Chen; Mao Zhao

Abstract

Many investigators have suggested that different cytokines may be important players in the development and progression of cancer and tumor biology. Cytokines are integral to many different aspects of cancer, including development/advancement, treatment, and prognosis. However, so far most cytokine -based therapy trials have fallen short of expectations. One of main obstacles is the difficulty to achieve therapeutically relevant dosage in patients without generating excessive normal tissue toxicity. Furthermore, cytokine profile levels have been used to predict cancer prognosis as differential cytokine expression profiles have been correlated with disease progression. Cytokines can also influence the effectiveness of cancer treatments. Elevated cytokine levels have been associated with reducing the anti-cancer activity of various treatments. In this review, we demonstrated the applicable action of cytokines in cancer pathogenesis and treatment.

Key words: Cytokine; Cancer; IL-6; IL-1β; TNF-α


Limited Access             Full Text-PDF                Feedback


References

1. Luo Y, Henning J, O'Donnell MA. Th1 cytokine-secreting recombinant Mycobacterium bovis bacillus Calmette-Guérin and prospective use in immunotherapy of bladder cancer.Clin Dev Immunol 2011;2011:728930. [Pubmed]

2. Chen H, Sampath P, Hou W, Thorne SH. Regulating cytokine function enhances safety and activity of genetic cancer therapies. Mol Ther 2013; 21(1):167-74. [PubMed]

3. Riancho JA, Zarrabeitia MT, Amado JA, Olmos JM, Gonzalez-Macias J. Age-related differences in cytokine secretion. Gerontology 1994;40: 8–12. [PubMed]

4. Fulop T, Larbi A, Kotb R, de Angelis F, Pawelec G. Aging, immunity, and cancer. Discov Med 2011; 11: 537–550. [PubMed]

5. Bonafe M, Storci G, Franceschi C. Inflamm-aging of the stem cell niche: breast cancer as a paradigmatic example: breakdown of the multi-shell cytokine network fuels cancer in aged people. Bioessays 2012; 34: 40–49. [PubMed]

6. Kumar SK, Rajkumar SV, Dispenzieri A, et al. Improved survival in multiple myeloma and the impact of novel therapies. Blood 2008;111: 2516–2520. [PubMed]

7. Jemal A, Siegel R, Xu J, Ward E, “Cancer statistics,” CA Cancer Journal for Clinicians 2010; 60: 277–300. [PubMed]

8. Chang DH, Osman K, Connolly J, et al. Sustained expansion of NKT cells and antigen-specific T cells after injection of alpha-galactosyl-ceramide loaded mature dendritic cells in cancer patients. J Exp Med 2005;201: 1503–1517. [PubMed]

9. Kim JM, Stewart R, Kim SY, et al. A one year longitudinal study of cytokine genes and depression in breast cancer. J Affect Disord. 2013;148(1):57-65. [PubMed]

10. Gonda TA, Tu S, Wang TC. Chronic inflammation, the tumor microenvironment and carcinogenesis. Cell Cycle 2009; 8: 2005–2013. [PubMed]

11. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 210;140: 883–899. [PubMed]

12. Smith AJ, Humphries SE. Cytokine and cytokine receptor gene polymorphisms and their functionality. Cytokine Growth Factor Rev 2009; 20: 43–59. [PubMed]

13. Liu YC, Ho HC, Lee MR, et al. Early induction of cytokines/cytokine receptors and Cox2, and activation of NF-kappaB in 4-nitroquinoline 1-oxide-induced murine oral cancer model. Toxicol Appl Pharmacol 2012; 262: 107–116. [PubMed]

14. Jack M. Neuzillet jm, Traynor C,  Hullmann G, Tyritzis G, Shimizu J. TNF-α-induced IL-32 expression in esophageal cancer: cross talk JNK/Akt signaling pathways. American Journal of BioMedicine 2013; 12:73-85. [Abstract/Full-Text]

15. Yousif NG. Fibronectin promotes migration and invasion of ovarian cancer cells through up-regulation of FAK-PI3K/Akt pathway. Cell Biol Int 2014;38(1):85-91. [PubMed]

16. Gaur P, Mittal M, Mohanti BK, Das SN. Functional genetic variants of TGF-beta1 and risk of tobacco-related oral carcinoma in high-risk Asian Indians. Oral Oncol 2011;47: 1117–1121. [PubMed]

17. Liu CJ, Wong YK, Chang KW, et al. Tumor necrosis factor-alpha promoter polymorphism is associated with susceptibility to oral squamous cell carcinoma. J Oral Pathol Med 2005;34:608–612. [PubMed]

18. Kietthubthew S, Wickliffe J, Sriplung H, et al.  Association of polymorphisms in proinflammatory cytokine genes with the development of oral cancer in Southern Thailand. Int J Hyg Environ Health 2010; 213:146–152. [PubMed]

19. Sica A, Schioppa T, Mantovani A, Allavena P. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 2006;42: 717–727. [PubMed]

 

American Journal of Biomedicine © 2017 Frontier Theme
%d bloggers like this: